CrossrefInfokarte
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Rheumatology and Therapy · 2024-10 · 11 (5) · 1363-1382
DOI: 10.1007/s40744-024-00708-8 ↗Abstract
Kein Abstract verfügbar.
EUVIMED